Almotriptan and Dorzolamide interaction
Almotriptan and Dorzolamide: the Almotriptan prescribing label describes an interaction that usually calls for monitoring, a dose change, or spacing the doses.
Usually manageable with monitoring or a dose change. Tell your pharmacist you take both.
What the FDA labels say
From the Almotriptan label · effective 2025-12-31
Use with caution in patients with a known hypersensitivity to sulfonamides ( 5.8 )
Hypersensitivity to Sulfonamides Caution should be exercised when prescribing almotriptan tablets to patients with known hypersensitivity to sulfonamides.
The chemical structure of almotriptan contains a sulfonyl group, which is structurally different from a sulfonamide.
Cross-sensitivity to almotriptan in patients allergic to sulfonamides has not been systematically evaluated.
Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.
Open in the checkerNot medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.